Share-based Payment Arrangement, Expense of COGNITION THERAPEUTICS INC from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
COGNITION THERAPEUTICS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • COGNITION THERAPEUTICS INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $522,000, a 42% decline year-over-year.
  • COGNITION THERAPEUTICS INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $2,263,000, a 47% decline year-over-year.
  • COGNITION THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2024 was $3,748,000, a 14% decline from 2023.
  • COGNITION THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2023 was $4,354,000, a 22% increase from 2022.
  • COGNITION THERAPEUTICS INC annual Share-based Payment Arrangement, Expense for 2022 was $3,572,000, a 31% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

COGNITION THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,263,000 $522,000 -$374,000 -42% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $2,637,000 $621,000 -$526,000 -46% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $3,163,000 $586,000 -$585,000 -50% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $3,748,000 $534,000 -$537,000 -50% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $4,285,000 $896,000 -$175,000 -16% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $4,460,000 $1,147,000 +$122,000 +12% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $4,338,000 $1,171,000 -$16,000 -1.3% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $4,354,000 $1,071,000 +$169,000 +19% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $4,185,000 $1,071,000 +$294,000 +38% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $3,891,000 $1,025,000 +$133,000 +15% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $3,758,000 $1,187,000 +$186,000 +19% 01 Jan 2023 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $3,572,000 $902,000 -$4,017,000 -82% 01 Oct 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $7,589,000 $777,000 +$705,000 +979% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $6,884,000 $892,000 +$798,000 +849% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $6,086,000 $1,001,000 +$903,000 +921% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $5,183,000 $4,919,000 01 Oct 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $72,000 -$57,000 -44% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $94,000 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $98,000 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q3 2020 $129,000 01 Jul 2020 30 Sep 2020 10-Q 17 Nov 2021 2021 Q3

COGNITION THERAPEUTICS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,748,000 -$606,000 -14% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $4,354,000 +$782,000 +22% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $3,572,000 -$1,611,000 -31% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $5,183,000 +$4,708,000 +991% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2020 $475,000 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.